Shares of this under-the-radar cell therapy stock are set to double, says Baird
Baird initiated coverage of bluebird bio with an outperform rating and $10 price target, which implies 104% upside from Monday's close.
Source link
- Turkey's Opposition Unsure on Embracing Pro-Kurdish Party – Latest Tweet by Reuters – LatestLY
- UNESCO-listed Monumental Mount Nemrut statues survive Türkiye quakes – Anadolu Agency | English
